128 filings
Page 3 of 7
8-K
qoowzaf lg97y8xe
7 Nov 23
Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates
7:45am
8-K
w2pfzzz
16 Oct 23
Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors
4:30pm
8-K
b0ss7a vlispdt7e
8 Aug 23
Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates
7:30am
EFFECT
4kglkw2ck5vlju4s
28 Jun 23
Notice of effectiveness
12:15am
8-K
e8wl71n
27 Jun 23
Fusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R
4:01pm
CORRESP
0bk24
23 Jun 23
Correspondence with SEC
12:00am
UPLOAD
fh7st yprzqo
23 Jun 23
Letter from SEC
12:00am
8-K
0vl9 fw18j
20 Jun 23
Submission of Matters to a Vote of Security Holders
8:00am
8-K
m0um6r5qqwpdp233p7
11 May 23
Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates
7:46am
ARS
t3sj3sxh0 tsfp70
27 Apr 23
Annual report to shareholders
4:43pm
DEFA14A
8yim9bgi3
27 Apr 23
Additional proxy soliciting materials
4:34pm
EFFECT
9coau nqsp2aik5qnu
24 Mar 23
Notice of effectiveness
12:15am
CORRESP
tz0yps2k dujkus
21 Mar 23
Correspondence with SEC
12:00am
UPLOAD
26m8xrx
21 Mar 23
Letter from SEC
12:00am
S-8
pm2f0q
16 Mar 23
Registration of securities for employees
8:16am